By Hemai Parthasarathy

Lost in Translation: How Can Science Have an Impact on Society Without Entrepreneurs Carrying Ideas Into the Marketplace?

posted on October 20th, 2014

Of the so-called academic pursuits, scientific research is disproportionately well funded. Grants for biomedical research easily value in the millions of dollars; the same cannot be said of grants to art historians or archaeologists. The reason…

» Continue Reading
Breakout Lab_2014-54

By Breakout Labs

Unboxing 2014 in pictures

posted on October 15th, 2014

Our Unboxing event last week was a huge success! (if we do say so ourselves). We loved having all of our portfolio companies together and sharing their progress with our network. Here are a few photographic highlights…

» Continue Reading

By Breakout Labs

Cortexyme receives new funding for Alzheimer’s research from Dolby Family Ventures

posted on October 6th, 2014

As reported in today’s Wall Street Journal, Dolby Family Ventures is placing some exciting bets on early-stage treatments for Alzheimer’s disease, alongside Google’s CEO Eric Schmidt and (of course!) Breakout Labs. Breakout Labs portfolio company Cortexyme received a $500,000…

» Continue Reading

By Breakout Labs

Pareto Biotechnologies featured in SynBioBeta’s first industry report

posted on September 24th, 2014

SynBioBeta brought out a new service to the synthetic biology community: industry reports.  And the first company they have chosen to feature is our very own Pareto Biotechnologies.  The report is free: SynBioBeta is offering all…

» Continue Reading

By Breakout Labs

Fortune Magazine talks with Breakout Labs founder Peter Thiel about advancing radical science in an age of “tech stagnation”

posted on September 10th, 2014

Breakout Labs founder Peter Thiel recently spoke with Fortune Magazine‘s Roger Parloff about the “19 futuristic startups” that have received funding from our program thus far, and what’s inspiring him to focus on breakthroughs in biotech. (BOL…

» Continue Reading